Back

Featured

Category
Showing 21-30 of 37 results
Filter
  • Stuart Bell
  • Posted by Stuart Bell
30/09/2021
5 min read

When Early Access Programs Go Bad

Lorem ipsum dolor sit amet, consectetur adipiscing elit....

Read More
  • morten.gron
  • Posted by morten.gron
28/06/2021
2 min read

Oasmia announces transfer of Nordic commercialization rights for Apealea® (Paclitaxel Micellar) to Inceptua

Lorem ipsum dolor sit amet, consectetur adipiscing elit....

Read More
  • Inceptua
  • Posted by Inceptua
14/01/2021
5 min read

Is there a role for Ethics Committees in Early Access?

Lorem ipsum dolor sit amet, consectetur adipiscing elit....

Read More
  • Inceptua
  • Posted by Inceptua
28/12/2020
2 min read

Elevar Therapeutics Inc. Announces Licensing Agreement with Inceptua Group

Lorem ipsum dolor sit amet, consectetur adipiscing elit....

Read More
  • Inceptua
  • Posted by Inceptua
03/12/2020
4 min read

Inceptua Partners with Global Blood Therapeutics for an Early Access Program for Voxelotor for Patients with Sickle Cell Disease

Lorem ipsum dolor sit amet, consectetur adipiscing elit....

Read More
  • Inceptua
  • Posted by Inceptua
30/11/2020
4 min read

Webinar: Strategic Comparator Sourcing in China

Lorem ipsum dolor sit amet, consectetur adipiscing elit....

Read More
  • Inceptua
  • Posted by Inceptua
02/11/2020
2 min read

Safely and Reliably Supplying your Comparator Needs during COVID19

Lorem ipsum dolor sit amet, consectetur adipiscing elit....

Read More
  • Inceptua
  • Posted by Inceptua
07/10/2020
6 min read

Helping get orphan drugs to patients quicker

Lorem ipsum dolor sit amet, consectetur adipiscing elit....

Read More
  • Inceptua
  • Posted by Inceptua
25/09/2020
4 min read

Inceptua receives approval of marketing authorization transfer of Jetrea® (ocriplasmin) for the treatment of symptomatic vitreomacular adhesion

Lorem ipsum dolor sit amet, consectetur adipiscing elit....

Read More
  • Inceptua
  • Posted by Inceptua
26/06/2020
4 min read

Inceptua Group Announces Partnership with BioCryst on Expanded Access Program for Patients with Hereditary Angioedema

Lorem ipsum dolor sit amet, consectetur adipiscing elit....

Read More